Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
CLOSE ×
Search
Leaving AARP.org Website

You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

New Research on Women and Heart Disease

The latest on why their heart attacks go undetected, how they may benefit from half doses of cholesterol drugs, and more


spinner image Woman's hand holding white pills next to a heart outline of white pills
Getty Images

Doctors have known for years that men and women experience heart disease somewhat differently. It’s long been clear, for instance, that before menopause, women are less likely to develop heart disease than men. This is thanks to the protection estrogen provides, and it’s a key reason why the average age for a heart attack is 64 for men but 72 for women. Women catch up quickly, though, making heart disease the leading cause of death for both sexes overall during non-pandemic times.

But new research is changing cardiologists’ understanding of heart disease in women. Take, for instance, the symptoms of a heart attack. With women, doctors have for some time been taught to look for “atypical” signs, including heartburn, back pain, or pain that is burning, stabbing or resembles indigestion. With men, they expect more “typical” symptoms, including chest, jaw or arm pain; pain that radiates to one of the arms, neck, jaw or back; and nausea, vomiting, sweating or palpitations. But recent research shows women are just as likely to experience the “classic” signs as men. A study of nearly 2,000 patients published recently in the Journal of the American Heart Association found that women’s most common symptoms were chest pain and aches radiating down the left arm.

This is just one of several recent findings — with more included below — that shed light on sex-related differences in the diagnosis and treatment of heart disease.

Younger women are at greater risk of death

Women have fewer heart attacks than men, but they tend to fare worse during them. To find out why, researchers at the Mayo Clinic in Rochester, Minnesota, examined hospital data on nearly 7 million heart attack patients. In a study published in January in Mayo Clinic Proceedings, they showed that women who are hospitalized with a heart attack are less likely than men to receive life-saving treatments, such as angioplasty, in which clogged arteries are opened, and mechanical circulatory support, in which devices are used to improve blood flow.

Lead researcher Mohamad Alkhouli, M.D., an interventional cardiologist at the Mayo Clinic, speculates that doctors may hold back on these treatments because they believe women won’t fare as well during such surgeries. The researchers also discovered that women under age 65 were more likely than men to die from a heart attack — especially when they suffer from a type in which the coronary artery is significantly but not completely blocked.

More menopause symptoms may mean more risk

While it’s long been known that the plummeting estrogen levels of menopause reduce the hormone’s protection of the heart, new research shows that greater suffering from menopause’s hot flashes or sleep disturbances may signal greater cardiovascular risks. When researchers from medical centers across the country followed more than 20,000 women ages 50 to 79 for a median of seven years, they found a link between having two or more moderate or severe menopause symptoms and increased risk of things like heart attack and stroke.

The researchers, who published their findings in the medical journal Menopause, offer several possible explanations. For one, severe hot flashes are associated with artery stiffness, inflammation and vascular problems, which are linked to heart disease. In addition, bothersome menopause symptoms may compromise women’s ability to get adequate exercise and sleep, in turn harming heart health.

Heart risks also increase during perimenopause

New research from the American Heart Association, published in Circulation, shows that the hormonal shifts that occur during perimenopause — the years preceding menopause — set the stage for heart disease. “As women transition, they experience many changes that, when taken together, increase their risk of cardiovascular disease,” says lead researcher Samar R. El Khoudary, Ph.D., associate professor of epidemiology at the University of Pittsburgh. During this time, “bad” LDL cholesterol begins to rise; “good” HDL cholesterol may stop being protective; body fat accumulates in the abdomen instead of the hips; and insomnia and depression may occur, she says. El Khoudary suggests seeing perimenopause as a critical time to start lowering heart disease risk with practices like regular exercise and prioritized sleep.

Breast cancer’s links to blood clots, heart failure and more

Unfortunately, breast cancer survivors over age 65 have another health risk to worry about: heart problems. A study published in January in the Journal of the National Comprehensive Cancer Network found that survivors were at greater risk of life-threatening blood clots called deep vein thrombosis, arrhythmia, heart failure, heart valve disease and sudden cardiac arrest compared to women who had not had cancer.

In the study, while these conditions were seen most often during the first year after diagnosis, the heightened risk remained for five years. At highest risk were Black women and women with stage 3 and hormone receptor-negative breast cancer. For all, ill effects of the chemotherapy drugs used to battle cancer may partly explain the findings, the researchers say. Lifestyle differences may also play a role, since women who smoke, are obese or have a more sedentary lifestyle are prone to both breast cancer and heart disease.

Hector R. Villarraga, M.D., a cardiologist at the Mayo Clinic in Rochester, Minnesota, recommends that breast cancer survivors get an echocardiogram, which produces images of the heart, five years after their cancer treatment ends. If you were treated with radiation, ask your doctor about having a cardiac stress test 10 years after you’ve completed treatment, he says.

Sussing out “hidden” heart attacks with better imaging

Most heart attacks are caused by blockages in the large arteries of the heart. But in up to 15 percent of cases in which people experience symptoms such as chest pain and shortness of breath, there are no significant blockages. These little-understood heart attacks, known as myocardial infarction with non-obstructive coronary arteries (MINOCAs), can still cause heart damage and are also three times more likely to occur in women.

“Sometimes women come to a hospital with heart attack symptoms and, after they get tested, they’re told they didn’t have a heart attack,” says Harmony Reynolds, M.D., a cardiologist and director of the Sarah Ross Soter Center for Women’s Cardiovascular Research at NYU Langone Health in New York. That’s because an angiogram — the test that’s used to evaluate patients with heart attack symptoms — may not reveal the underlying cause, says Reynolds. Without knowing what’s causing patients’ symptoms, doctors aren’t able to treat them.

To pinpoint the causes of MINOCAs, Reynolds and researchers from several institutions used advanced imaging tests called cardiac MRIs and coronary optical coherence tomography (OCT). They were able to identify the causes of these otherwise undetected heart attacks in more than 100 women, and they published their findings in the journal Circulation. The causes they observed included hidden plaque ruptures that, like a blockage, stopped blood flow to the heart, and spasms in the coronary artery, which can temporarily close the artery, cutting off blood flow.

If you experienced symptoms of a heart attack but were told you didn’t have one, consider asking your doctor (or one affiliated with an academic medical center) if you should have one of these advanced imaging tests, advises Reynolds.

Drug doses designed for men may not be best for women

Men and women with heart disease generally receive the same prescriptions. But when it comes to heart failure — in which the heart is unable to pump enough blood to meet the body’s needs — they probably shouldn’t, according to a new study published in The Lancet. The researchers found that women have the lowest rates of death and hospitalization when they are given half the standard dosages of ACE inhibitors, angiotensin-receptor blockers (ARBs) and/or beta blockers. Men, on the other hand, fare best with the full prescription.

The researchers speculate that weight differences may explain these findings. Children’s drugs are typically prescribed by weight, but this is rarely done for adults, explains Joyce Oen-Hsiao, M.D., director of clinical cardiology at Yale Medicine, who was not involved with the study. Other possible reasons include sex hormones and differences in the way drugs are absorbed, metabolized and excreted.

Unlock Access to AARP Members Edition

Join AARP to Continue

Already a Member?